The SR Protein SC35 Is Responsible for Aberrant Splicing of the E1α Pyruvate Dehydrogenase mRNA in a Case of Mental Retardation with Lactic Acidosis

REFERENCES

• Allemand, E., S. Dokudovskaya, R. Bordonne, and J. Tazi. 2002. A conserved Drosophila transportin-serine/arginine-rich (SR) protein permits nuclear import of Drosophila SR protein splicing factors and their antagonist repressor splicing factor 1. Mol. Biol. Cell 13:2436–2447.
   PubMedGoogle Scholar
• Blencowe, B. J. 2000. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. 25:106–110.
   PubMed Web of Science ®Google Scholar
• Brown, G. K., L. J. Otero, M. LeGris, and R. M. Brown. 1994. Pyruvate dehydrogenase deficiency. J. Med. Genet. 31:875–879.
   PubMed Web of Science ®Google Scholar
• Caputi, M., A. Mayeda, A. R. Krainer, and A. M. Zahler. 1999. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J. 18:4060–4067.
   PubMed Web of Science ®Google Scholar
• Cardozo, A. K., L. De Meirleir, I. Liebaers, and W. Lissens. 2000. Analysis of exonic mutations leading to exon skipping in patients with pyruvate dehydrogenase E1 alpha deficiency. Pediatr. Res. 48:748–753.
   PubMedGoogle Scholar
• Cartegni, L., and A. R. Krainer. 2002. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet. 30:377–384.
   PubMed Web of Science ®Google Scholar
• Cartegni, L., S. L. Chew, and A. R. Krainer. 2002. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3:285–298.
   PubMed Web of Science ®Google Scholar
• Cartegni, L., and A. R. Krainer. 2003. Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat. Struct. Biol. 10:120–125.
   PubMedGoogle Scholar
• Cartegni, L., J. Wang, Z. Zhu, M. Q. Zhang, and A. R. Krainer. 2003. ESE finder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31:3568–3571.
   PubMed Web of Science ®Google Scholar
• Chun, K., N. MacKay, R. Petrova-Benedict, A. Federico, A. Fois, D. E. Cole, E. Robertson, and B. H. Robinson. 1995. Mutations in the X-linked E1 alpha subunit of pyruvate dehydrogenase: exon skipping, insertion of duplicate sequence, and missense mutations leading to the deficiency of the pyruvate dehydrogenase complex. Am. J. Hum. Genet. 56:558–569.
   PubMedGoogle Scholar
• Dahl, H. H., G. K. Brown, R. M. Brown, L. L. Hansen, D. S. Kerr, I. D. Wexler, M. S. Patel, L. De Meirleir, W. Lissens, K. Chun, N. Mackay, and B. H. Robinson. 1992. Mutations and polymorphisms in the pyruvate dehydrogenase E1 α gene. Hum. Mutat. 1:97–102.
   PubMedGoogle Scholar
• De Meirleir, L., W. Lissens, C. Benelli, G. Ponsot, I. Desguerre, C. Marsac, D. Rodriguez, J. M. Saudubray, F. Poggi, and I. Liebaers. 1994. Aberrant splicing of exon 6 in the pyruvate dehydrogenase-E1 alpha mRNA linked to a silent mutation in a large family with Leigh's encephalomyelopathy. Pediatr. Res. 36:707–712.
   PubMedGoogle Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Doench, J. G., C. P. Petersen, and P. A. Sharp. 2003. siRNAs can function as miRNAs. Genes Dev. 17:438–442.
   PubMed Web of Science ®Google Scholar
• D'Souza, I., P. Poorkaj, M. Hong, D. Nochlin, V. M. Lee, T. D. Bird, and G. D. Schellenberg. 1999. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. USA 96:5598–5603.
   PubMed Web of Science ®Google Scholar
• Elbashir, S. M., J. Harborth, K. Weber, and T. Tuschl. 2002. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26:199–213.
   PubMed Web of Science ®Google Scholar
• Faustino, N. A., and T. A. Cooper. 2003. Pre-mRNA splicing and human disease. Genes Dev. 17:419–437.
   PubMed Web of Science ®Google Scholar
• Fu, X. D. 1995. The superfamily of arginine/serine-rich splicing factors. RNA 1:663–680.
   PubMed Web of Science ®Google Scholar
• Graveley, B. R. 2000. Sorting out the complexity of SR protein functions. RNA 6:1197–1211.
   PubMed Web of Science ®Google Scholar
• Hofmann, Y., C. L. Lorson, S. Stamm, E. J. Androphy, and B. Wirth. 2000. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl. Acad. Sci. USA 97:9618–9623.
   PubMed Web of Science ®Google Scholar
• Jiang, Z., H. Tang, N. Havlioglu, X. Zhang, S. Stamm, R. Yan, and J. Y. Wu. 2003. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. J. Biol. Chem. 278:18997–19007.
   PubMed Web of Science ®Google Scholar
• Johnson, J. M., J. Castle, P. Garrett-Engele, Z. Kan, P. M. Loerch, C. D. Armour, R. Santos, E. E. Schadt, R. Stoughton, and D. D. Shoemaker. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141–2144.
   PubMed Web of Science ®Google Scholar
• Kalbfuss, B., S. A. Mabon, and T. Misteli. 2001. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17. J. Biol. Chem. 276:42986–42993.
   PubMed Web of Science ®Google Scholar
• Kashima, T., and J. L. Manley. 2003. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat. Genet. 34:460–463.
   PubMed Web of Science ®Google Scholar
• Kohtz, J. D., S. F. Jamison, C. L. Will, P. Zuo, R. Luhrmann, M. A. Garcia-Blanco, and J. L. Manley. 1994. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 368:119–124.
   PubMed Web of Science ®Google Scholar
• Krawczak, M., J. Reiss, and D. N. Cooper. 1992. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 90:41–54.
   PubMed Web of Science ®Google Scholar
• Labourier, E., E. Allemand, S. Brand, M. Fostier, J. Tazi, and H. M. Bourbon. 1999. Recognition of exonic splicing enhancer sequences by the Drosophila splicing repressor RSF1. Nucleic Acids Res. 27:2377–2386.
   PubMedGoogle Scholar
• Labourier, E., H. M. Bourbon, I. Gallouzi, M. Fostier, E. Allemand, and J. Tazi. 1999. Antagonism between RSF1 and SR proteins for both splice site recognition in vitro and Drosophila development. Genes Dev. 13:740–753.
   PubMedGoogle Scholar
• Ladd, A. N., and T. A. Cooper. 2001. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol. 3:1–16.
   Google Scholar
• Lissens, W., L. De Meirleir, S. Seneca, C. Benelli, C. Marsac, B. T. Poll-The, P. Briones, W. Ruitenbeek, O. van Diggelen, D. Chaigne, V. Ramaekers, and I. Liebaers. 1996. Mutation analysis of the pyruvate dehydrogenase E1 alpha gene in eight patients with a pyruvate dehydrogenase complex deficiency. Hum. Mutat. 7:46–51.
   PubMedGoogle Scholar
• Lissens, W., L. De Meirleir, S. Seneca, I. Liebaers, G. K. Brown, R. M. Brown, M. Ito, E. Naito, Y. Kuroda, D. S. Kerr, I. D. Wexler, M. S. Patel, B. H. Robinson, and A. Seyda. 2000. Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum. Mutat. 15:209–219.
   PubMed Web of Science ®Google Scholar
• Liu, H. X., L. Cartegni, M. Q. Zhang, and A. R. Krainer. 2001. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat. Genet. 27:55–58.
   PubMed Web of Science ®Google Scholar
• Manley, J. L., and R. Tacke. 1996. SR proteins and splicing control. Genes Dev. 10:1569–1579.
   PubMed Web of Science ®Google Scholar
• Marsac, C., C. Benelli, I. Desguerre, M. Diry, F. Fouque, L. De Meirleir, G. Ponsot, S. Seneca, F. Poggi, J. M. Saudubray, M. T. Zabot, D. Fontan, and W. Lissens. 1997. Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1 alpha deficiency. Hum. Genet. 99:785–792.
   PubMedGoogle Scholar
• Mercatante, D. R., and R. Kole. 2002. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression. Biochim. Biophys. Acta 1587:126–132.
   PubMed Web of Science ®Google Scholar
• Mine, M., M. Brivet, G. Touati, P. Grabowski, M. Abitbol, and C. Marsac. 2003. Splicing error in E1 alpha pyruvate dehydrogenase mRNA caused by novel intronic mutation responsible for lactic acidosis and mental retardation. J. Biol. Chem. 278:11768–11772.
   PubMedGoogle Scholar
• Nissim-Rafinia, M., O. Chiba-Falek, G. Sharon, A. Boss, and B. Kerem. 2000. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations. Hum. Mol. Genet. 9:1771–1778.
   PubMedGoogle Scholar
• Robinson, B. H. 1995. Lactic acidemia (disorders of pyruvate carboxylase, pyruvate dehydrogenase), p. 1479–1499. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, N.Y.
   Google Scholar
• Rossi, F., E. Labourier, T. Forne, G. Divita, J. Derancourt, J. F. Riou, E. Antoine, G. Cathala, C. Brunel, and J. Tazi. 1996. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 381:80–82.
   PubMed Web of Science ®Google Scholar
• Sazani, P., F. Gemignani, S. H. Kang, M. A. Maier, M. Manoharan, M. Persmark, D. Bortner, and R. Kole. 2002. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. 20:1228–1233.
   PubMed Web of Science ®Google Scholar
• Tacke, R., and J. L. Manley. 1999. Determinants of SR protein specificity. Curr. Opin. Cell Biol. 11:358–362.
   PubMedGoogle Scholar
• Wu, J. Y., and T. Maniatis. 1993. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75:1061–1070.
   PubMed Web of Science ®Google Scholar
• Zhu, J., A. Mayeda, and A. R. Krainer. 2001. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol. Cell 8:1351–1361.
   PubMedGoogle Scholar
• Zuo, P., and T. Maniatis. 1996. The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing. Genes Dev. 10:1356–1368.
   PubMedGoogle Scholar